Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy

被引:115
作者
Raza, Faisal [1 ]
Zafar, Hajra [1 ]
Zhang, Shulei [1 ]
Kamal, Zul [1 ,2 ]
Su, Jing [1 ]
Yuan, Wei-En [1 ]
Qiu, Mingfeng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China
[2] Shaheed Benazir Bhutto Univ, Dept Pharm, Khyber Pakhtunkhwa 18000, Pakistan
基金
上海市自然科学基金;
关键词
biomimetic nanoparticles; cancer immunotherapy; cell membranes; effective drug delivery; nanotechnology; IMMUNE CHECKPOINT BLOCKADE; ANTIGEN-PRESENTING CELLS; RED-BLOOD-CELLS; ERYTHROCYTE-MEMBRANE; DRUG-DELIVERY; MULTIFUNCTIONAL NANOPARTICLES; THERAPEUTIC VACCINES; COATED NANOPARTICLES; STRATEGIES; CARRIERS;
D O I
10.1002/adhm.202002081
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Immunotherapy will significantly impact the standard of care in cancer treatment. Recent advances in nanotechnology can improve the efficacy of cancer immunotherapy. However, concerns regarding efficiency of cancer nanomedicine, complex tumor microenvironment, patient heterogeneity, and systemic immunotoxicity drive interest in more novel approaches to be developed. For this purpose, biomimetic nanoparticles are developed to make innovative changes in the delivery and biodistribution of immunotherapeutics. Biomimetic nanoparticles have several advantages that can advance the clinical efficacy of cancer immunotherapy. Thus there is a greater push toward the utilization of biomimetic nanotechnology for developing effective cancer immunotherapeutics that demonstrate increased specificity and potency. The recent works and state-of-the-art strategies for anti-tumor immunotherapeutics are highlighted here, and particular emphasis has been given to the applications of cell-derived biomimetic nanotechnology for cancer immunotherapy.
引用
收藏
页数:27
相关论文
共 136 条
[1]   Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications [J].
Ai, Xiangzhao ;
Hu, Ming ;
Wang, Zhimin ;
Zhang, Wenmin ;
Li, Juan ;
Yang, Huanghao ;
Lin, Jun ;
Xing, Bengang .
BIOCONJUGATE CHEMISTRY, 2018, 29 (04) :838-851
[2]  
Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
[3]   Delivery of Polysaccharides Using Polymer Particles: Implications on Size-Dependent Immunogenicity, Opsonophagocytosis, and Protective Immunity [J].
Anish, Chakkumkal ;
Khan, Naeem ;
Upadhyay, Arun Kumar ;
Sehgal, Lleyinder ;
Panda, Amulya Kumar .
MOLECULAR PHARMACEUTICS, 2014, 11 (03) :922-937
[4]   Targeted and stimuli-responsive mesoporous silica nanoparticles for drug delivery and theranostic use [J].
Aquib, Md ;
Farooq, Muhammad A. ;
Banerjee, Parikshit ;
Akhtar, Fahad ;
Filli, Mensura S. ;
Boakye-Yiadom, Kofi O. ;
Kesse, Samuel ;
Raza, Faisal ;
Maviah, Mily B. J. ;
Mavlyanova, Rukhshona ;
Wang, Bo .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2019, 107 (12) :2643-2666
[5]   Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles [J].
Arvizo, Rochelle R. ;
Miranda, Oscar R. ;
Moyano, Daniel F. ;
Walden, Chad A. ;
Giri, Karuna ;
Bhattacharya, Resham ;
Robertson, J. David ;
Rotello, Vincent M. ;
Reid, Joel M. ;
Mukherjee, Priyabrata .
PLOS ONE, 2011, 6 (09)
[6]   The Possible "Proton Sponge" Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH [J].
Benjaminsen, Rikke V. ;
Mattebjerg, Maria A. ;
Henriksen, Jonas R. ;
Moghimi, S. Moein ;
Andresen, Thomas L. .
MOLECULAR THERAPY, 2013, 21 (01) :149-157
[7]   Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology [J].
Bertrand, Nicolas ;
Wu, Jun ;
Xu, Xiaoyang ;
Kamaly, Nazila ;
Farokhzad, Omid C. .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 66 :2-25
[8]   Understanding the tumor immune microenvironment (TIME) for effective therapy [J].
Binnewies, Mikhail ;
Roberts, Edward W. ;
Kersten, Kelly ;
Chan, Vincent ;
Fearon, Douglas F. ;
Merad, Miriam ;
Coussens, Lisa M. ;
Gabrilovich, Dmitry I. ;
Ostrand-Rosenberg, Suzanne ;
Hedrick, Catherine C. ;
Vonderheide, Robert H. ;
Pittet, Mikael J. ;
Jain, Rakesh K. ;
Zou, Weiping ;
Howcroft, T. Kevin ;
Woodhouse, Elisa C. ;
Weinberg, Robert A. ;
Krummel, Matthew F. .
NATURE MEDICINE, 2018, 24 (05) :541-550
[9]   Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose [J].
Chahal, Jasdave S. ;
Khan, Omar F. ;
Cooper, Christopher L. ;
McPartlan, Justine S. ;
Tsosie, Jonathan K. ;
Tilley, Lucas D. ;
Sidik, Saima M. ;
Lourido, Sebastian ;
Langer, Robert ;
Bavari, Sina ;
Ploegh, Hidde L. ;
Anderson, Daniel G. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (29) :E4133-E4142
[10]   A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery [J].
Chai, Zhilan ;
Hu, Xuefeng ;
Wei, Xiaoli ;
Zhan, Changyou ;
Lu, Linwei ;
Jiang, Kuan ;
Su, Bingxia ;
Ruan, Huitong ;
Ran, Danni ;
Fang, Ronnie H. ;
Zhang, Liangfang ;
Lu, Weiyue .
JOURNAL OF CONTROLLED RELEASE, 2017, 264 :102-111